Decreases in TBT concentrations in southern Chesapeake Bay: Evidence for long-term TBT degradation and reduced imposex in the invasive gastropod, Rapana venosa.

This study assessed effectiveness of regulations reducing environmental butyltin concentrations in Southern Chesapeake Bay over the 1999-2021 period. Water column monitoring of the Elizabeth River from 1999 to 2006 demonstrated decreasing TBT from 2003 to 2006 (average >1 ng/L at most stations) to <1 ng L by 2019 but with higher concentrations of degradation products DBT and MBT. TBT degrades to DBT and MBT within sediments, and releases degradation products over time.

Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial.

Adequate secondary prevention in survivors of intracerebral hemorrhage (ICH) who also have atrial fibrillation (AF) is a long-standing clinical dilemma because these patients are at increased risk of recurrent ICH as well as of ischemic stroke. The efficacy and safety of oral anticoagulation, the standard preventive medication for ischemic stroke patients with AF, in ICH patients with AF are uncertain. PRESTIGE-AF is an international, phase 3b, multi-center, randomized, open, blinded end-point assessment (PROBE) clinical trial that compared the efficacy and safety of direct oral anticoagulants (DOACs) with no DOAC (either no antithrombotic treatment or any antiplatelet drug).

Early Detection of Compartment Syndrome With Minimal Symptoms: A Case Report on Continuous Pressure Monitoring.

Compartment syndrome (CS) arises from various etiologies but is most commonly associated with severe traumatic injuries. It is a difficult diagnosis to make in a timely fashion because clinical signs and symptoms are subjective. Missing the diagnosis is a devastating mistake for the patient and the physician.